Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Vanessa Hasle"'
Autor:
Amer M. Zeidan, Jan Philipp Bewersdorf, Vanessa Hasle, Rory M. Shallis, Ethan Thompson, Daniel Lopes de Menezes, Shelonidta Rose, Isaac Boss, Stephanie Halene, Torsten Haferlach, Brian A. Fox
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Background: TP53 mutations are associated with an adverse prognosis in acute myeloid leukemia (AML) and higher-risk myelodysplastic syndromes (HR-MDS). However, the integrated genetic, epigenetic, and immunologic landscape of TP53 -mutated AML/HR-MDS
Externí odkaz:
https://doaj.org/article/607d9f5536614146a1ff9b6d9aed6dd7
Autor:
Jan Philipp Bewersdorf, Vanessa Hasle, Rory Michael Shallis, Ethan G. Thompson, Daniel Lopes de Menezes, Shelonitda Rose, Isaac W. Boss, Stephanie Halene, Torsten Haferlach, Brian Fox, Amer M. Zeidan
Publikováno v:
Blood. 140:6247-6249
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ede1941e7ebc32a71c8fa9b6868ce109
https://doi.org/10.1182/blood-2022-156460
https://doi.org/10.1182/blood-2022-156460
Autor:
Amer M. Zeidan, Jan Philipp Bewersdorf, Vanessa Hasle, Rory M. Shallis, Ethan Thompson, Daniel Lopes de Menezes, Shelonidta Rose, Isaac Boss, Stephanie Halene, Torsten Haferlach, Brian Fox
Publikováno v:
Leukemia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53cdb70cf4242a2e0780d1a6892eb768
https://pubmed.ncbi.nlm.nih.gov/36437356
https://pubmed.ncbi.nlm.nih.gov/36437356
Autor:
Jan Philipp Bewersdorf, Vanessa Hasle, Rory Michael Shallis, Ethan G. Thompson, Daniel Lopes de Menezes, Shelonitda Rose, Isaac W. Boss, Stephanie Halene, Torsten Haferlach, Brian Fox, Amer M. Zeidan
Publikováno v:
Blood. 140:8910-8911
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0a45aaf4cb5ec31d2307c87e1979458
https://doi.org/10.1182/blood-2022-158592
https://doi.org/10.1182/blood-2022-158592
Autor:
Ethan G. Thompson, Shelonitda Rose, Vanessa Hasle, Brian Fox, Amer M. Zeidan, Isaac Boss, Daniel Menezes, Jan Philipp Bewersdorf
Publikováno v:
Blood. 138:3371-3371
Introduction: Mutations in TP53 occur in 10% of patients (pts) with AML and HR-MDS and have been associated with worse outcomes and an immunosuppressive phenotype. To define the immune and epigenetic landscape in TP53-M advanced myeloid neoplasms (MN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a80431c164e7ac03eb57c5dc5b12faee
https://doi.org/10.1182/blood-2021-146329
https://doi.org/10.1182/blood-2021-146329